The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
29-May-07
$99.1 billion
Target:
ABN AMRO Holding NV
Acquiror:
Fortis SA/NV, The Royal Bank of Scotland Group plc, Banco Santander Central Hispano, SA
Advised Fortis on an offer by Fortis, RBS and Santander for ABN AMRO
30-Jun-07
$52.0 billion
Target:
BCE Inc.
Acquiror:
Teacher's Private Capital, Providence Equity Partners Inc. and Madison Dearborn Partners, LLC
Advised the Board of BCE on a review of a range of strategic alternatives that culminated in an agreement to sell to a consortium consisting of Teacher's Private Capital, Providence Equity Partners and Madison Dearborn Partners for $52.0 billion that was ultimately terminated
11-Dec-12
$51.6 billion
Target:
American International Group (AIG)
Advised the United States Department of the Treasury (“UST”) on the full reduction of its 92% ownership stake in the insurer through numerous Secondary Public Offering Transactions
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
15-Dec-19
$45.4 billion
Target:
Nutrition & Biosciences Division of DuPont de Nemours, Inc.
Acquiror:
International Flavors and Fragrances, Inc.
Advising IFF, a global leader in flavors and fragrances, on its merger with DuPont’s Nutrition & Biosciences Division, creating a clear global leader in the specialty ingredients sector
27-Jul-15
$40.5 billion
Target:
Allergan Generics
Acquiror:
Teva Pharmaceutical Industries Ltd.
Advised Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, on the acquisition of Allergan plc’s Generics business
18-Feb-14
$25.1 billion
Target:
Forest Laboratories Inc.
Acquiror:
Actavis plc
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
16-Apr-07
$25.0 billion
Target:
SLM Corporation
Acquiror:
J.C. Flowers, Friedman Fleischer & Lowe, Bank of America and JPMorgan Chase
Advised the Transaction Committee of the Board of Directors of SLM Corporation, commonly known as Sallie Mae, on the sale to a consortium consisting of J.C. Flowers, Friedman Fleischer & Lowe, Bank of America and JPMorgan Chase
28-May-19
$25.0 billion
Target:
Total System Services, Inc. (TSYS)
Acquiror:
Global Payments Inc.
Advised Total System Services, Inc. (TSYS), a provider of payment processing, merchant services and related payment services, on its merger with Global Payments Inc., a payment technology company focused on merchant acquiring and software solutions
30-Mar-07
$24.4 billion
Target:
Alliance Boots plc
Acquiror:
Kohlberg Kravis Roberts & Co. Ltd. and Stefano Pessina
Advised Alliance Boots plc, the leading international pharmacy-led health and beauty group, on a proposal regarding an offer for the company from a consortium comprising of Kohlberg Kravis Roberts & Co. Ltd. and Stefano Pessina
04-Oct-99
$23.5 billion
Target:
AMFM, Inc.
Acquiror:
Clear Channel Communications, Inc.
Advised AMFM on the sale of the company to Clear Channel Communications to form the largest US radio company
24-Mar-06
$21.2 billion
Target:
Schering AG
Acquiror:
Bayer AG
Advised Bayer on its public offer for Schering, an international pharmaceuticals group based in Berlin, Germany
09-Aug-02
$17.6 billion
Target:
Adelphia Communications
Acquiror:
Time Warner Inc. and Comcast Corp.
Advised the Unsecured Creditors of Adelphia Communications representing $14.5 billion of value in Adelphia’s Chapter 11 proceedings. Advised on the sale of Adelphia’s assets to Time Warner and Comcast for $17.6 billion
17-Oct-05
$16.8 billion
Target:
Refco
Acted as the exclusive financial advisor to Refco Inc. in connection with its Chapter 11 proceedings which included the sale of substantially all of the assets of Refco's regulated commodities futures business to Man Financial for $1.2 billion
25-Feb-10
$14.4 billion
Target:
Coca-Cola Enterprises Inc.
Acquiror:
The Coca-Cola Company
Advised the Affiliated Transaction Committee of Coca-Cola Enterprises Inc. on the sale of its North American bottling operations to The Coca-Cola Company and on its concurrent acquisition of The Coca-Cola Company’s bottling operations in the Nordic region
27-Mar-18
$13.0 billion
Target:
Novartis AG’s 36.5% stake in Consumer Health Joint Venture
Acquiror:
GlaxoSmithKline plc
Advised and acted as sponsor to GlaxoSmithKline plc, the UK’s leading pharmaceutical company, on the buyout of Novartis’ 36.5% stake in their Consumer Health Joint Venture
15-Dec-10
$12.9 billion
Target:
Alcon, Inc.
Acquiror:
Novartis AG
Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company
06-Aug-99
$12.8 billion
Target:
One2One
Acquiror:
Deutsche Telekom AG
(joint venture between Cable and Wireless plc and Media One)
Strategic advice to C&W in connection with the sale of One2One, a UK mobile phone operator, 50% owned by C&W and 50% owned by Media One
16-Jan-01
$11.5 billion
Target:
Ralston Purina Co.
Acquiror:
Nestlé S.A.
Advised Nestlé on the agreed cash offer for the US pet-food company Ralston Purina
06-Aug-08
$10.7 billion
Target:
Lonmin plc
Acquiror:
Xstrata plc
Advised Lonmin plc, a major producer of Platinum Group Metals, regarding an unsolicited pre-conditional offer for the company by Xstrata plc, a global diversified mining company
17-Jul-00
$10.5 billion
Target:
Diageo plc
Acquiror:
General Mills, Inc.
Advised Diageo on the sale of The Pillsbury Company for $5.1 billion in assumed debt and $5.4 billion in stock to General Mills.
05-Feb-15
$10.5 billion
Target:
Wireline assets of Verizon Communications in California, Florida and Texas
Acquiror:
Frontier Communications
Advised the Board of Directors of Frontier in connection with its acquisition of wireline assets from Verizon in California, Florida and Texas
06-Mar-14
$10.0 billion
Target:
Safeway Inc.
Acquiror:
Albertsons (majority owned by Cerberus Capital Management)
Advised the Board of Directors of Safeway Inc., a leading food and drug retailer, on its acquisition by Albertsons
22-Feb-22
Pending
~$8.6 billion
Target:
TEGNA, Inc.
Acquiror:
Standard General
Advising TEGNA, a leading broadcasting and digital marketing services company, on its sale to Standard General, a hedge fund
20-May-13
$8.5 billion
Target:
Warner Chilcott, plc
Acquiror:
Actavis, Inc.
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc